Skip Navigation
News
Contact
Toggle Navigation
Search:
Search Submit
Company
About
Our Team
Board of Directors
Science
Our Science
Radiotherapy-Induced Toxicity
Radiotherapy Anti-Cancer Efficacy
Scientific Publications
Pipeline
Our Pipeline
Patients & Caregivers
Investors
IR Home
Press Releases
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
Shareholder Services
Contact
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
